AI virtual drug trial investigation Ecosystem
AI firms test virtual drug trials, but human studies remain essential
Developing 1 source
A
AI virtual drug trial investigation
News Oct 8, 2026
Reuters examined BioinvestGPT's predictions for real drug trials and the wider use of simulated patients, while documenting a wrong call and the continuing need for human studies.
1 source attached
What happened lately
AI virtual drug trial investigation timeline
Reuters reported on October 7 that AI companies are testing simulated patients to assess potential drug-trial outcomes. BioinvestGPT had shared predictions with the news agency before several study results were known, and Reuters said five of six subsequent calls matched the outcomes. The system also incorrectly predicted success for a Novartis drug that failed in a late-stage trial. Other forecasts cited in the report concern studies that have not yet reported results. Simulations may help choose which candidates to investigate, but they do not replace human clinical evidence.